Selected Publications

Chugh R et al.: THE TETRAVALENT DEATH RECEPTOR 5 AGONIST INBRX-109 COMBINED WITH CHEMOTHERAPY IN EWING SARCOMA: PRELIMINARY DATA FROM A PHASE 1 STUDY CTOS Annual Meeting : 2023.

Van Tine B et al.: RANDOMIZED PHASE II TRIAL OF CABOZANTINIB COMBINED WITH PD-1 AND CTLA-4 INHIBITION VERSUS CABOZANTINIB IN METASTATIC SOFT TISSUE SARCOMA. CTOS Annual Meeting : 2023.

Gounder M et al.: Nirogacestat, a γ-Secretase Inhibitor for Desmoid Tumors. New England Journal of Medcine 388 (10): 898-921,2023.

Gounder MM, Razak AA, Somaiah N, et al.: Selinexor in Advanced, Metastatic Dedifferentiated Liposarcoma: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial. J Clin Oncol. 40 (22): 2479-2490,2022.

Jia H, Roberson D, Luo X, Kovell RC, Hartner L, Harryhill JF.: Primary follicular lymphoma of the prostate presenting with elevated PSA and a PI-RADS 3 lesion on MRI: A case report. Urol Case Rep. : 2022.

Brody RM, Shimunov D, Cohen RB, et al.: A benchmark for oncologic outcomes and model for lethal recurrence risk after transoral robotic resection of HPV-related oropharyngeal cancers. Oral Oncol. : 2022.

Civantos AM, Prasad A, Carey RM, Bur AM, Mady LJ, Brody RM, Rajasekaran K, Cannady SB, Hartner L, Ibrahim SA, Newman JG, Brant JA.: Palliative care in metastatic head and neck cancer Head Neck 43 (9): 2764-2777,2021.

Reddy VK, Jain V, Wilson Ii RJ, Hartner LP, Diamond M, Sebro RA, Weber KL, Maki RG, Shabason JE.: Adult Pleomorphic Rhabdomyosarcomas: Assessing Outcomes Associated with Radiotherapy and Chemotherapy Use in the National Cancer Database Sarcoma 2021 : 9712070,2021.

Baumann BC, Bernstein KA, DeLaney TF, Simone CB 2nd, Kolker JD, Choy E, Levin WP, Weber KL, Muniappan A, Berman AT, Staddon A, Hartner L, Van Tine B, Hirbe A, Glatstein E, Hahn SM, Nagda SN, Chen YL.: Multi-institutional analysis of stereotactic body radiotherapy for sarcoma pulmonary metastases: High rates of local control with favorable toxicity J Surg Oncol 122 (5): 877-883,2020.

Chow W, Frankel P, Ruel C, Araujo DM, Milhem M, Okuno S, Hartner L, Undevia S, Staddon A.: Results of a prospective phase 2 study of pazopanib in patients with surgically unresectable or metastatic chondrosarcoma Cancer 126 (1): 105-111,2020.

Academic Contact Information

Pennsylvania Hematology Oncology at Pennsylvania Hospital
230 West Washington Square, 2nd Floor
Philadelphia, PA 19106
Phone: 215-829-6088
Patient appointments: 800-789-7366